Surgical wound management is an important part of patient care before, during, and after a procedure. Once an incision is made or tissue is disrupted, the body begins a complex healing process that involves clotting, inflammation, tissue formation, collagen activity, and remodeling. While every patient and procedure is different, surgical teams often use advanced wound management products to help support the local wound environment.
CellerateRX® Surgical Powder is one of the surgical products offered by Sanara MedTech, a Fort Worth-based medical technology company focused on developing and commercializing products for surgical, wound care, and tissue repair markets. Sanara’s surgical portfolio includes CellerateRX® Surgical Powder, BIASURGE® Advanced Surgical Solution, FORTIFY® products, TEXAGEN®, ALLOCYTE® Plus, ACTIGEN™, and other advanced technologies designed for use by healthcare professionals.
What Is CellerateRX® Surgical Powder?
CellerateRX® Surgical Powder is a Type I bovine hydrolyzed collagen product that aids in the management of surgical wounds. It is designed to provide the benefits of hydrolyzed collagen directly to the wound bed as part of a clinician’s surgical wound management protocol.
Collagen is a major structural protein found throughout the body. It plays a role in skin, connective tissue, and the wound healing process. In surgical wound care, collagen-based products may be used to help create a wound environment that supports the body’s natural healing activity.
The key distinction with CellerateRX® Surgical Powder is that it uses hydrolyzed collagen. Hydrolyzed collagen has been broken down into smaller amino acids and peptides. Sanara’s product material explains that hydrolyzed collagen fragments do not have to be broken down by the body before use, which helps make the collagen components available to the wound bed.
What Types of Wounds Is It Used For?
CellerateRX® Surgical Powder is intended for use in the management of several wound types, including surgical wounds, traumatic wounds, partial-thickness wounds, full-thickness wounds, and first- and second-degree burns.
In surgical settings, wound needs can vary based on the patient, procedure, tissue condition, location of the wound, and overall health factors. For example, some patients may have a higher risk of wound complications due to factors such as obesity, diabetes, peripheral vascular disease, immune-related deficiencies, or prior surgeries.
Because of these variables, product selection should always be based on the healthcare provider’s clinical judgment, the current product instructions, the surgical environment, and the patient’s individual needs.
How Does CellerateRX® Surgical Powder Support the Wound Bed?
The wound bed is the area where healing activity takes place. A properly managed wound bed helps support tissue repair and allows the body’s natural healing process to progress.
CellerateRX® Surgical Powder provides hydrolyzed collagen to the wound bed. Sanara’s product material describes Type I collagen properties that support surgical wound progression, including hemostatic, chemotactic, and adhesive properties.
In practical terms, this means the powder is designed to support the local wound environment by adding collagen components to the surgical site. It does not replace proper surgical technique, infection control, wound assessment, closure methods, or postoperative care. Instead, it is used as one part of a larger surgical wound management approach.
How Is CellerateRX® Surgical Powder Applied?
The application process is designed to fit within an established surgical workflow. Sanara describes the general process in three steps: prepare the surgical wound site, apply CellerateRX® Surgical Powder to the wound, and cover the surgical wound according to the healthcare provider’s protocol.
This simple application sequence may help surgical teams incorporate the product into existing procedures when appropriate. The specific method, amount used, timing, and wound coverage should be determined by the healthcare provider and current product guidance.
CellerateRX® Surgical Powder is sterilized and packaged for use in the operating room. It is also compatible with Negative Pressure Wound Therapy, commonly referred to as NPWT, when used as part of a wound management plan.
Why Does Hydrolyzed Collagen Matter?
The difference between native collagen and hydrolyzed collagen is important for understanding the product’s role.
Native collagen has a larger molecular structure and must be broken down before the body can use its smaller components. Sanara’s materials describe native collagen as insoluble, larger in molecule size, and higher in molecular weight. Hydrolyzed collagen is described as collagen fragmented into amino acids and peptides, making it soluble, smaller in molecule size, and lower in molecular weight.
This difference helps explain why hydrolyzed collagen products may be useful in wound management. By providing collagen in a smaller fragmented form, the product is designed to make collagen components available at the wound bed without requiring the same breakdown process as native collagen.
Where May It Be Used in Surgical Care?
Sanara identifies CellerateRX® Surgical Powder as appropriate for many surgical wounds and lists examples such as hip replacement, total knee arthroplasty revision, superficial femoral artery bypass, lower extremity arterial ulcer limb salvage, Achilles tendon procedures, thoracolumbar spine repair, spinal deformity and thoracolumbar fusion, and cesarean section.
These examples show the broad surgical relevance of wound management support. However, they should not be read as a guarantee that the product is appropriate for every patient or procedure. The treating healthcare professional must determine whether CellerateRX® Surgical Powder fits the clinical situation.
How Does It Fit Into Sanara MedTech’s Product Portfolio?
Sanara MedTech provides a range of advanced products for surgical, wound care, and tissue repair needs. Its surgical portfolio includes collagen products, surgical irrigation solutions, extracellular matrix products, tissue repair grafts, amniotic membrane allografts, viable bone matrices, and inductive bone matrix products.
CellerateRX® Surgical Powder fits within this portfolio as a hydrolyzed collagen product focused on surgical wound management. It supports Sanara’s broader mission of helping healthcare professionals access advanced technologies designed for healing-focused clinical care.
What Should Healthcare Professionals Consider?
When evaluating CellerateRX® Surgical Powder, healthcare professionals should consider:
- The type of wound being managed
- The patient’s risk factors
- The procedure being performed
- The condition of the tissue
- Facility protocols
- Current product instructions
- Compatibility with other wound management methods
- Postoperative care requirements
No wound product works in isolation. Surgical outcomes depend on many factors, including the patient’s health, blood flow, nutrition, infection prevention, surgical technique, wound closure, and follow-up care.
Learn More About CellerateRX® Surgical Powder
CellerateRX® Surgical Powder is a Type I bovine hydrolyzed collagen product designed to aid in the management of surgical wounds. By providing hydrolyzed collagen to the wound bed, it can serve as part of a thoughtful surgical wound management protocol under the direction of qualified healthcare professionals.
Sanara MedTech works with hospitals, surgery centers, wound care providers, physician groups, and other healthcare organizations to provide advanced products for surgical, wound care, and tissue repair markets.
